CYDY - CytoDyn: What To Do When It's Too Good To Be True?
CytoDyn (CYDY) is a full fledged penny stock with an exciting story to tell. The premise of this posting is that it has so much sizzle that it is entirely too hot to handle. I am staying away, at least for the time being.
CytoDyn plans on its paradigm shifting PRO 140 rapidly taking a major share of the HIV-AIDS therapeutic market.
I first became interested in CytoDyn when I saw that it kept appearing in diverse comment streams as a potential winner. I also recalled that one of Seeking Alpha's marketplace panel